EILY LILY
Why MNC pharma companies are realigning their India operationsAt a time when the local market is assuming the centre stage of the growth strategy for Indian pharma companies, multinational drugmakers a...- Lupin: Valuations, margins to challenge growthConcerns over stagnancy in its US business, margin pressures and peaking valuations may limit further gains in Lupin stock price.
- Load More